Curated News
By: NewsRamp Editorial Staff
April 25, 2024
Petros Pharmaceuticals Partners with Lemonaid Health to Expand Distribution of STENDRA®
Discuss on Reddit
Discuss on SubstackTLDR
- Petros Pharmaceuticals expands STENDRA® distribution through collaboration with Lemonaid Health, gaining an advantage in the telemedicine market.
- Lemonaid Health's telehealth platform will now offer prescription STENDRA® (avanafil) in all strengths, enhancing patient access and distribution.
- This collaboration improves patient access to essential medications, making healthcare delivery more streamlined and accessible for those with erectile dysfunction.
- Petros Pharmaceuticals' collaboration with Lemonaid Health opens up new opportunities in the telemedicine market, benefiting patients with erectile dysfunction.
Impact - Why it Matters
The collaboration between Petros Pharmaceuticals and Lemonaid Health will enhance access to prescription STENDRA® for patients with erectile dysfunction, potentially streamlining the healthcare delivery process and improving patient outcomes.
Summary
Petros Pharmaceuticals CEO Fady Boctor announced a collaboration with Lemonaid Health, expanding distribution of prescription STENDRA® (avanafil) through Lemonaid Health's telehealth platform. Boctor also highlighted positive results of an initial cohort in Petros' self-selection study, which aims to provide compelling evidence to the FDA.
Source Statement
This curated news summary relied on this press release disributed by News Direct. Read the source press release here, Petros Pharmaceuticals Partners with Lemonaid Health to Expand Distribution of STENDRA®
